Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Code:
NCT05272241
Conditions
Asthma
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Accepted
Brief summary:
Conditions
Asthma
Study ID
NCT05272241
Start date
May 6, 2022
Status verified date
Aug, 2026
Completion date
May, 2027
Anticipated
Primary completion date
May, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Accepted
Enrollment
1500 participants
Anticipated
Primary outcome measure
Locations
Children's Hospital Colorado: Allergy Program
Recruiting
Aurora, Colorado, United States, 80045
Contacts
Principal Investigator:
Andrew Liu, MD
Children's National Medical Center: Inner City Asthma Consortium (ICAC) Clinical Research Site
Recruiting
Washington D.C., District of Columbia, United States, 20010
Contacts
Principal Investigator:
Stephen Teach, MD
Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology
Recruiting
Chicago, Illinois, United States, 60611
Contacts
Principal Investigator:
Rajesh Kumar, MD
Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute
Recruiting
New York, New York, United States, 10029
Contacts
Principal Investigator:
Paula Busse, MD
Cincinnati Children's Hospital Medical Center: Asthma Center
Recruiting
Cincinnati, Ohio, United States, 45229
Contacts
Principal Investigator:
Neeru Hershey, MD
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Last update posted
Aug 21, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by National Institute of Allergy and Infectious Diseases (NIAID) on 2026-08-21.